In 1999 was created Turenne Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Paris. The fund was located in Europe if to be more exact in France.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Turenne Capital, startups are often financed by Naxicap Partners, Innovacom, Highland Europe. The meaningful sponsors for the fund in investment in the same round are Paca Investissement, XAnge, Nord Capital. In the next rounds fund is usually obtained by XAnge, TempoCap, Sofimac Partners.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Notilo Plus, Fidzup, Dromadaire.com We can highlight the next thriving fund investment areas, such as Education, Software.
The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Turenne Capital works on 22 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2016. The usual things for fund are deals in the range of 1 - 5 millions dollars.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Antabio | $29M | 12 Dec 2023 | France, Auvergne-Rhône-Alpes, France | ||
AlgoTherapeutix | $23M | 14 Mar 2023 | Suresnes, Ile-de-France, France | ||
Amolyt Pharma | $153M | 06 Jan 2023 | Écully, Rhone-Alpes, France | ||
Domain Therapeutics | $46M | 10 May 2022 | France, Grand Est, France | ||
PathoQuest | $17M | 09 Nov 2021 | Paris, Ile-de-France, France | ||
AI Verse | $2M | 01 Sep 2021 | Sophia Antipolis, Provence-Alpes-Cote d'Azur, France | ||
$23M | 14 Dec 2020 | France, Provence-Alpes-Côte d'Azur | |||
Exotrail | $13M | 16 Jul 2020 | France, Ile-de-France | ||
MCES | $2M | 05 Jul 2020 | Marseille, Provence-Alpes-Côte d'Azur, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Antabio | $29M | 12 Dec 2023 | France, Auvergne-Rhône-Alpes, France | ||
AlgoTherapeutix | $23M | 14 Mar 2023 | Suresnes, Ile-de-France, France | ||
Amolyt Pharma | $153M | 06 Jan 2023 | Écully, Rhone-Alpes, France | ||
Domain Therapeutics | $46M | 10 May 2022 | France, Grand Est, France | ||
PathoQuest | $17M | 09 Nov 2021 | Paris, Ile-de-France, France | ||
AI Verse | $2M | 01 Sep 2021 | Sophia Antipolis, Provence-Alpes-Cote d'Azur, France | ||
$23M | 14 Dec 2020 | France, Provence-Alpes-Côte d'Azur | |||
Exotrail | $13M | 16 Jul 2020 | France, Ile-de-France | ||
MCES | $2M | 05 Jul 2020 | Marseille, Provence-Alpes-Côte d'Azur, France |